Walleye Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,627	Closed	-$96K	–	2782
2022 Q3	$96K	Sell	1,627 -191,212	-99%	-$11.3M	﹤0.01%	1687
2022 Q2	$5.44M	Buy	192,839 +173,475	+896%	+$4.9M	0.15%	149
2022 Q1	$731K	Buy	19,364 +10,792	+126%	+$407K	0.02%	770
2021 Q4	$339K	Buy	+8,572	New	+$339K	0.01%	1147